Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 17/20 | 0.69 |
| ▸ | CDK12 | Q9NYV4 | 17/20 | 0.69 |
| ▸ | CCNE1 | P24864 | 9/20 | 0.69 |
| ▸ | CDK2 | P24941 | 9/20 | 0.69 |
| ▸ | CCNT1 | O60563 | 8/20 | 0.69 |
| ▸ | CDK9 | P50750 | 8/20 | 0.69 |
| ▸ | CDK7 | P50613 | 12/20 | 0.64 |
| ▸ | CCNH | P51946 | 12/20 | 0.64 |
| ▸ | MNAT1 | P51948 | 11/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28817275 | 1.00 | CCNK (0.69) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL28817263 | 0.90 | CCNK (0.72) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL28817259 | 0.90 | CCNK (0.72) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL30260751 | 0.88 | CCNK (0.64) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25595631 | 0.88 | CCNK (0.72) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25595637 | 0.88 | CCNK (0.72) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25595680 | 0.88 | CCNK (0.66) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL30204027 | 0.88 | CCNK (0.72) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL30204041 | 0.88 | CCNK (0.66) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25597338 | 0.88 | CDK7 (0.59) | CCNKCDK12CCNE1CDK2CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114907407-A | Inhibitors of cyclin dependent kinase 7(CDK7) | 江苏先声药业有限公司 | 2022-08-16 | — | — | CN | disclosed |